Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
1181530 B.C. Ltd. was a Canadian technology company primarily known for developing and operating Buds2go.ca, a major online platform for medical and recreational marijuana. The company created a robust e-commerce ecosystem that specialized in high-ranking search engine optimization (SEO) and organic traffic, attracting approximately 400,000 monthly visitors at its peak. In November 2018, the company sold its core digital assets—including the domain name, social media accounts, and intellectual property—to CannMart Inc., a subsidiary of Namaste Technologies (now Lifeist Wellness), for a cash consideration of $300,000. Following the asset sale, the 1181530 B.C. Ltd. management team provided specialized consulting services to assist in integrating its patient database and search technology into the acquirer's regulated cannabis distribution infrastructure. The company was a significant player in the early digital commercialization of cannabis-based wellness products in the Canadian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 1181530 B.C. Ltd..